https://norapharma.ca/ 2026-10-06T21:05:27+00:00 https://norapharma.ca/en/ 2026-10-06T21:05:27+00:00 https://norapharma.ca/norapharma-entente-lancement-biosimilaire/ 2022-02-01T12:33:57+00:00 https://norapharma.ca/en/norapharma-agreement-launch-biosimilar-canada/ 2022-02-01T12:40:31+00:00 https://norapharma.ca/nora-pharma-poursuit-son-elan-de-croissance-en-faisant-lacquisition-dactifs-de-pharmapar/ 2022-03-01T09:45:46+00:00 https://norapharma.ca/en/nora-pharma-continues-its-growth-momentum-by-acquiring-assets-of-pharmapar/ 2022-03-01T09:50:02+00:00 https://norapharma.ca/application-spontanee/ 2023-03-09T17:19:40+00:00 https://norapharma.ca/sunshine-biopharma-acquiert-nora-pharma-une-compagnie-pharmaceutique-canadienne-en-pleine-emergence/ 2023-06-19T08:20:33+00:00 https://norapharma.ca/en/sunshine-biopharma-announces-the-acquisition-of-nora-pharma-adding-10-7-million-in-revenue/ 2023-06-19T08:29:17+00:00 https://norapharma.ca/nora-pharma-recoit-lapprobation-de-sante-canada-pour-niopeg-un-biosimilaire-de-neulasta/ 2024-04-19T10:57:21+00:00 https://norapharma.ca/en/nora-pharma-receives-health-canada-approval-for-niopeg-a-biosimilar-of-neulasta/ 2024-04-19T11:00:38+00:00 https://norapharma.ca/cercle-des-futurs-associes-besoin-de-conseils-bancaires/ 2024-12-13T10:02:39+00:00 https://norapharma.ca/un-nouveau-chapitre-pour-nora-pharma-catherine-peloquin-prend-le-relais-a-la-presidence/ 2025-09-25T15:21:02+00:00 https://norapharma.ca/en/a-new-chapter-for-nora-pharma-catherine-peloquin-takes-over-as-president/ 2025-09-25T15:31:19+00:00